Creation of the WIC

In an effort led by SITC Past President, Bernard Fox, PhD, a collaborative group of international and domestic organizations similarly interested in promoting research and translation of cancer immunotherapy prepared a joint publication that defines the critical hurdles in cancer immunotherapy. “Defining the Critical Hurdles in Cancer Immunotherapy” was published in the Journal of Translational Medicine in 2011.

Following the publication, SITC convened the World Immunotherapy Council (WIC) inaugural summit on February 21-24, 2012 in Curacao. Scientific sessions at the meeting focused on several of the hurdles identified in the "Defining the Critical Hurdles in Cancer Immunotherapy" manuscript including mechanisms of immune escape, immunological monitoring, and prognostic and predictive biomarkers.

Founding Organizations

  • Adoptive Engineered T Cell Targeting to Activate Cancer Killing (ATTACK)
  • Australian Working Group
  • Biotherapy Development Association (BDA)
  • Canadian Cancer Immunotherapy Consortium (CCIC)
  • Cancer Immunotherapy Consortium - Cancer Research Institute (CIC-CRI)
  • Association for Cancer Immunotherapy (CIMT)
  • Cancer Research Institute (CRI)
  • Chinese Society of Clinical Oncology (CSCO)
  • Dutch Tumor Immunology Working Party (DTIWP) *now KWF working society-Dutch Tumor Immunology Meeting (KWF-DTIM)
  • European Academy of Tumor Immunology (EATI)
  • European Society of Cancer Immunology and Immunotherapy (ESCII)
  • Center for Immune Modulatory Therapies for Autoimmunity and Cancer (IMTAC)
  • Japanese Association of Cancer Immunology (JACI)
  • Scandinavian Network for Immunotherapy of Cancer (SNIC)
  • Italian Network for Tumor Biotherapy (NIBIT)
  • Progress In Vaccination Against Cancer (PIVAC)
  • Society for Immunotherapy of Cancer (SITC)
  • Committee for Tumor Immunology and Bio-Therapy (TIBT) *now Tumor Immunotherapy and Biological Therapy
  • Tumor Vaccine and Cell Therapy Working Group (TVACT)

Active WIC Organizations

  • Australia and New Zealand Society for Immunology (ASI)
  • Canadian Cancer Immunotherapy Consortium (CCIC)
  • Chinese American Hematology Oncology Network (CAHON)
  • Chinese Society for Clinical Oncology (CSCO)
  • Chinese Society for Immunology (CSI)/Tumor Immunotherapy and Biological Therapy (TIBT)
  • French Society for Immunotherapy of Cancer (FITC)
  • Hong Kong Cancer Therapy Society (HKCTS)
  • Immuno-Oncology Society of India (I-OSI)
  • Institute for Cancer Vaccines and Immunotherapy (ICVI)
  • Italian Network for Tumor Biotherapy (NIBIT)
  • Japanese Association of Cancer Immunology (JACI)
  • Korean Society for Medical Oncology (KSMO)
  • KWF working society-Dutch Tumor Immunology Meeting (KWF-DTIM)
  • Latin American and Caribbean Association for Immunology (ALACI)
  • Moroccan Society of Immunology (SMI)
  • Malaysian Society for Biochemistry & Molecular Biology (MSBMB)
  • Progress in Vaccination Against Cancer (PIVAC)
  • Scandinavian Network for Immunotherapy of Cancer (SNIC)
  • Singapore Society of Oncology - Cancer Immunotherapy Consortium (SSO-CIC)
  • Società Campana di ImmunoTerapia Oncologica (SCITO)
  • Society for Immunotherapy of Cancer (SITC)
  • Spanish Group of Immuno-Biological Therapeutics in Cancer (GETICA)
  • Thailand Hub of Talent for Cancer Immunotherapy (TTCI)
  • The Taiwan Society for Immunotherapy of Cancer (TSITC)
  • The Taiwanese Oncology Society (TOS)
  • TransMed-VN (Vietnam)
  • Tumor Immunology Meets Oncology (TIMO)

Previous Next

Historical WIC Activities

SITC World Immunotherapy Council (WIC) Young Investigator Symposium

This Symposium takes place at the SITC Annual Meeting and Pre-Conference Meetings every two years, providing the opportunity for young scientists and emerging leaders in the field of cancer immunotherapy from throughout the world to interact, fulfilling WIC’s mission to facilitate rapid development and global dissemination of cancer immunotherapies through scientific exchange. The young investigators, each chosen for exemplary work in the field of cancer immunotherapy, contribute insight and perspectives into present and future issues, challenges, and improvements as cancer immunotherapy is integrated into mainstream cancer treatment.

2025 Program2023 Program 2021 Program 2019 Program 2017 Program 2015 Program

2025 World Immunotherapy Council (WIC) Asia-Pacific Conference (WIC APAC)

The WIC-APAC Meeting will bring together young investigators throughout Asia with leaders in the field of immunotherapy to discuss the latest research discoveries and build lasting connections. Attendees can expect in-depth sessions on cutting-edge innovations, clinical applications, and the evolving landscape of immunotherapy in the Asia-Pacific region. Learn more about the program here.

2024 World Immunotherapy Council (WIC)-Asian Chapter Pre-Conference Meeting

The WIC-Asian Chapter Pre-Conference Meeting brought together young investigators throughout Asia with leaders in the field of immunotherapy to discuss the latest research discoveries and build lasting connections. The two-day meeting included talks from key opinion leaders, young investigator poster sessions, dedicated networking opportunities, and panel discussions. Learn more about the program here.